MedTrace Logo

Identification of Nerves Using Fluorescein Sodium

NCT06054178 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2026-05-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if there is benefit in using an IV contrast (sodium fluorescein) to identify nerves during head and neck surgery.

Conditions

  • Pleomorphic Adenoma of the Parotid
  • Warthin Tumor
  • Head and Neck Disorder
  • Head and Neck
  • Thyroid Disease
  • Thyroidectomy

Interventions

DRUG

Fluorescein Sodium

Intravenous administration of 1 mg/kg. If initial dosing is insufficient, additional doses may be administered up to a total of 3 mg/kg

Sponsors & Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

    collaborator NIH

  • Stanford University

    lead OTHER

Principal Investigators

  • Tulio Valdez, MD · Stanford University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-07
Primary Completion
2025-05-22
Completion
2025-05-22
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06054178 on ClinicalTrials.gov